How do detemir and glargine compare when added to oral agents in insulin-naïve patients with type 2 diabetes mellitus?

被引：5
|
作者：
Christoph Koenen
机构：
[1] Novo Nordisk A/S,
[2] Krogshøjvej 55,undefined
来源：
Nature Clinical Practice Endocrinology & Metabolism | 2008年 / 4卷 / 10期
关键词：
D O I：
10.1038/ncpendmet0972
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：E1 / E1
相关论文
共 50 条
  • [21] COMPARATIVE STUDY OF ANNUAL TREATMENT COST OF GLARGINE INSULIN AND DETEMIR INSULIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN MEXICO
    Reyes-Lopez, A.
    Lemus, A.
    Sil, M. J. S. A.
    Acevedo, G. A. R.
    VALUE IN HEALTH, 2009, 12 (07) : A507 - A507
  • [22] Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin-Naïve People with Type 2 Diabetes: the ATOS Study
    Gagik R. Galstyan
    Amir Tirosh
    Hernando Vargas-Uricoechea
    Maria Aileen Mabunay
    Mathieu Coudert
    Mubarak Naqvi
    Valerie Pilorget
    Niaz Khan
    Diabetes Therapy, 2022, 13 : 1187 - 1202
  • [23] Lilly Insulin Glargine Versus Lantus® in Insulin-Naïve and Insulin-Treated Adults with Type 2 Diabetes: A Randomized, Controlled Trial (ELEMENT 5)
    Robyn K. Pollom
    Liza L. Ilag
    Lyndon B. Lacaya
    Tina M. Morwick
    Ramón Ortiz Carrasquillo
    Diabetes Therapy, 2019, 10 : 189 - 203
  • [24] Exploring disparities: A comparative analysis of insulin-naïve, regular users, and inertia patients among type 2 diabetes mellitus outpatients in India
    Atal, Shubham
    Bohra, Arwa
    Kalra, Shamsher S.
    Balakrishnan, S.
    Joshi, Rajnish
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2024, 13 (10) : 4244 - 4251
  • [25] Intensified insulin therapy of type 2 diabetes mellitus: Insulin glargine vs. insulin detemir as basal insulin
    Jungmann, Eckart
    DIABETES, 2006, 55 : A118 - A118
  • [26] Comparison of Insulin Detemir and Insulin Glargine on Glycemic Variability in Patients with Type 1 and Type 2 Diabetes
    Tone, A.
    Iseda, I.
    Higuchi, C.
    Tsukamoto, K.
    Katayama, A.
    Matsushita, Y.
    Hida, K.
    Wada, J.
    Shikata, K.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2010, 118 (05) : 320 - 324
  • [27] COST-MINIMIZATION ANALYSIS COMPARING INSULIN GLARGINE TO INSULIN DETEMIR IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS PATIENTS IN BRAZIL
    Bahia, L.
    Teich, V
    VALUE IN HEALTH, 2009, 12 (07) : A506 - A506
  • [28] Insulin detemir results in less weight gain than NPH insulin when added to oral agents in type 2 diabetes, with this advantage increasing with baseline obesity
    Hermansen, K
    Tamer, SC
    DIABETOLOGIA, 2005, 48 : A4 - A5
  • [29] The advantage of less weight gain increases with baseline obesity when insulin detemir rather than NPH insulin is added to oral agents in type 2 diabetes
    Hermansen, K
    Tamer, SC
    DIABETES, 2005, 54 : A67 - A67
  • [30] Impact of concomitant oral glucose-lowering medications on the success of basal insulin titration in insulin-naïve patients with type 2 diabetes: a systematic analysis
    Wollenhaupt, Dominik
    Wolters, Jannik
    Abd El Aziz, Mirna
    Nauck, Michael A.
    BMJ OPEN DIABETES RESEARCH & CARE, 2023, 11 (04)
12345